However, there are few studies on its application in cervical cancer.8 Accordingly, this retrospective study was performed to compare the difference in efficacy of albumin-bound paclitaxel combined with lobaplatin through intravenous administration and interventional embolization by analyzing the clinical data of 108 cervical cancer patients. This evidence concerns the gene ALB and cervical cancer.